FibroGen (FGEN) Misses Q4 EPS by 13c

FibroGen (NASDAQ: FGEN) reported Q4 EPS of ($0.57), $0.13 worse than the analyst estimate of ($0.44). Revenue for the quarter came in at $27.1 million versus the consensus estimate of $38.78 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• H.B. Fuller makes £715M cash offer to acquire Advanced Medical Solutions
• Micron Technology (MU) PT Raised to $1,280 at Baird